CN Stock MarketDetailed Quotes

603676 Xizang Weixinkang Pharmaceutical

Watchlist
  • 9.87
  • -0.26-2.57%
Market Closed Nov 15 15:00 CST
4.30BMarket Cap17.38P/E (TTM)

Xizang Weixinkang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
Market service465.95M73.58%
Drugs167.16M26.40%
Other119.27K0.02%
Industry Currency:CNY
2024/H1
Stock NameRevenueRatio
市场服务及其他466.07M73.60%
Drug income167.16M26.40%
Region Currency:CNY
2024/H1
Stock NameRevenueRatio
East China region149.02M23.53%
North China141.69M22.38%
Central China107.69M17.01%
Southwest area83.38M13.17%
South China79.1M12.49%
Northwest region37.84M5.98%
Northeast area34.5M5.45%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data